Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Buring

Showing results (21-30 of 188) with videos related to

Pageof 19
Sort By:
Rational Drug Therapy|November 1, 1988
Aspirin and risk of cardiovascular diseaseC H Hennekens, J E Buring
Controlled Clinical Trials|December 1, 1989
Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health StudyC H Hennekens, J E Buring
Annals of Epidemiology|September 1, 1992
Ethics and epidemiologyJ E Buring, C H Hennekens
Novartis Foundation Symposium|February 9, 1999
Alcohol intake, lipids and risks of myocardial infarctionJ M Gaziano, J E Buring
The American Journal of Gastroenterology|September 1, 1991
Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive diseaseJ E Buring, C H Hennekens
Circulation|September 1, 1990
Antiplatelet therapy to prevent coronary artery bypass graft occlusionJ E Buring, C H Hennekens
Journal of Cardiovascular Risk|August 1, 1996
Antioxidants and coronary heart disease: weighing the totality of the evidenceJ E Buring, C H Hennekens
IARC Scientific Publications|January 1, 1990
Current issues in cancer chemopreventionJ E Buring, C H Hennekens
Cancer|November 1, 1994
Contributions of observational evidence and clinical trials in cancer preventionC H Hennekens, J E Buring
BMJ (Clinical Research Ed.)|February 10, 1996
Ways of measuring rates of recurrent eventsR J Glynn, J E Buring
Pageof 19

Showing results (21-30 of 188) with videos related to

Sort By:
Pageof 19
Rational Drug Therapy|November 1, 1988
Aspirin and risk of cardiovascular diseaseC H Hennekens, J E Buring
Controlled Clinical Trials|December 1, 1989
Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health StudyC H Hennekens, J E Buring
Annals of Epidemiology|September 1, 1992
Ethics and epidemiologyJ E Buring, C H Hennekens
Novartis Foundation Symposium|February 9, 1999
Alcohol intake, lipids and risks of myocardial infarctionJ M Gaziano, J E Buring
The American Journal of Gastroenterology|September 1, 1991
Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive diseaseJ E Buring, C H Hennekens
Circulation|September 1, 1990
Antiplatelet therapy to prevent coronary artery bypass graft occlusionJ E Buring, C H Hennekens
Journal of Cardiovascular Risk|August 1, 1996
Antioxidants and coronary heart disease: weighing the totality of the evidenceJ E Buring, C H Hennekens
IARC Scientific Publications|January 1, 1990
Current issues in cancer chemopreventionJ E Buring, C H Hennekens
Cancer|November 1, 1994
Contributions of observational evidence and clinical trials in cancer preventionC H Hennekens, J E Buring
BMJ (Clinical Research Ed.)|February 10, 1996
Ways of measuring rates of recurrent eventsR J Glynn, J E Buring
Pageof 19